MDT

85.79

-1.48%↓

112.06

+1.49%↑

VEEV

175.19

+1.67%↑

HQY

81.65

-1.05%↓

CSBR

5.56

-0.89%↓

MDT

85.79

-1.48%↓

112.06

+1.49%↑

VEEV

175.19

+1.67%↑

HQY

81.65

-1.05%↓

CSBR

5.56

-0.89%↓

MDT

85.79

-1.48%↓

112.06

+1.49%↑

VEEV

175.19

+1.67%↑

HQY

81.65

-1.05%↓

CSBR

5.56

-0.89%↓

MDT

85.79

-1.48%↓

112.06

+1.49%↑

VEEV

175.19

+1.67%↑

HQY

81.65

-1.05%↓

CSBR

5.56

-0.89%↓

MDT

85.79

-1.48%↓

112.06

+1.49%↑

VEEV

175.19

+1.67%↑

HQY

81.65

-1.05%↓

CSBR

5.56

-0.89%↓

Home・Listă Acțiuni・VolitionRX Ltd

VolitionRX Ltd

Închisă

0.18 -5.26

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

0.18

Maxim

0.19

Indicatori cheie
By Trading Economics
Venit	936K -5.4M
Vânzări	221K 627K
Marjă de profit	-857.414
Angajați	75
EBITDA	1.3M -4.2M

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+1400% upside

Dividende
By Dow Jones
Următoarele câștiguri	31 mar. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	-19M 28M
Deschiderea anterioară	5.44
Închiderea anterioară	0.18

VolitionRX Ltd Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

30 mar. 2026, 23:15 UTC

Evenimente importante

U.K. Shoppers Paid a Little More This Month But Worse May yet Lie Ahead

30 mar. 2026, 22:36 UTC

Evenimente importante

Australian Government Rules Out Boots on the Ground in the Middle East

30 mar. 2026, 22:13 UTC

Achiziții, Fuziuni, Preluări

Sun Life Financial Agrees to Buy Bell Partners for $350 Million

30 mar. 2026, 21:00 UTC

Câștiguri

Aktis Oncology Gets FDA Clearance for Phase 1 Billion Trial of Tumor Treatment

30 mar. 2026, 20:15 UTC

Evenimente importante

Fed's Williams: Middle-East Developments Have Added Significant Economic Uncertainty

30 mar. 2026, 23:40 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

30 mar. 2026, 23:40 UTC

Market Talk

Nikkei May Decline on Higher Energy Cost Concerns -- Market Talk

30 mar. 2026, 23:36 UTC

Market Talk

Gold Edges Lower Amid Divergent Signals on U.S.-Iran Talks -- Market Talk

30 mar. 2026, 23:12 UTC

Market Talk

Alcoa Earnings Outlook Boosted by Market Disruptions -- Market Talk

30 mar. 2026, 22:49 UTC

Market Talk

Fed's Williams: Core Inflation Forecast Is Little Changed -- Market Talk

30 mar. 2026, 22:44 UTC

Market Talk

Fed's Williams: Risks to Both Sides of Dual Mandate Higher -- Market Talk

30 mar. 2026, 22:43 UTC

Market Talk

Fed's Williams Says Focus Is on Inflation Expectations Being Well Anchored -- Market Talk

30 mar. 2026, 22:42 UTC

Market Talk

South32 Should Go for Growth, Says New Bull -- Market Talk

30 mar. 2026, 22:18 UTC

Market Talk

Paragon Care's Chances of Using Levy to Pass on Higher Costs `Close to Zero' -- Market Talk

30 mar. 2026, 22:05 UTC

Market Talk

Northern Star's New Bull Argues Case for Asset Sales -- Market Talk

30 mar. 2026, 21:58 UTC

Achiziții, Fuziuni, Preluări

Sun Life Financial Agrees to Buy Bell Partners for $350M

30 mar. 2026, 21:39 UTC

Achiziții, Fuziuni, Preluări

Sun Life Sees 1Q Charge to Net of C$236M From BGO, Crescent Deals

30 mar. 2026, 21:38 UTC

Achiziții, Fuziuni, Preluări

Sun Life: Completes Remaining Equity Interest Purchases of BGO, Crescent Capital

30 mar. 2026, 21:36 UTC

Achiziții, Fuziuni, Preluări

Sun Life to Buy Fully Bell Partners for $350M >SLF.T

30 mar. 2026, 21:33 UTC

Achiziții, Fuziuni, Preluări

Unilever Shareholders Expected to Own Two-Thirds of New Food Entity, Sources Say -- WSJ

30 mar. 2026, 21:33 UTC

Achiziții, Fuziuni, Preluări

Unilever Nears Deal to Create $60 Billion Food Giant With McCormick -- WSJ

30 mar. 2026, 21:33 UTC

Achiziții, Fuziuni, Preluări

Deal Could Be Announced As Soon As Tuesday, Sources Say -- WSJ

30 mar. 2026, 21:33 UTC

Achiziții, Fuziuni, Preluări

Unilever Nears Cash-and-Stock Deal to Combine Food Business With McCormick, Sources Say -- WSJ

30 mar. 2026, 21:33 UTC

Achiziții, Fuziuni, Preluări

Deal Set to Value Combined Food Business At Around $60B Including Debt, Sources Say -- WSJ

30 mar. 2026, 21:25 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

30 mar. 2026, 21:25 UTC

Market Talk

Warehouse Showing Cost Discipline But Margin Goal at Risk -- Market Talk

30 mar. 2026, 21:03 UTC

Achiziții, Fuziuni, Preluări

Sun Life: Completes Equity Interest Purchases of BGO and Crescent Cap, Announces Acquisition of Bell Partners, a Multifamily Real Estate Investment Manager

30 mar. 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

30 mar. 2026, 20:09 UTC

Câștiguri

This Stock Looks Like a Solid AI Bet -- and Wall Street Hasn't Noticed Yet -- Barrons.com

30 mar. 2026, 20:00 UTC

Evenimente importante

Fed's Williams: Middle-East Conflict 'Will Likely Boost Overall Inflation in Coming Months'

Comparație

Modificare preț

VolitionRX Ltd Așteptări

Obiectiv de preț

By TipRanks

1400% sus

Prognoză pe 12 luni

Medie 3 USD 1400%

Maxim 3 USD

Minim 3 USD

În baza a 1 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruVolitionRX Ltd - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

1 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 1 analiști care au acordat evaluări ale acțiunilor VolitionRX Ltd - Dist în ultimele 3 luni.

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre VolitionRX Ltd

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.